AGMB institutional holders
AGOMAB THERAPEUTICS NV · 13F, 2026Q2
| Managers holding | 34 |
|---|
| Shares held | 27,523,670 |
|---|
| Reported value | $357.3m |
|---|
| Quarter flows | 9 new, 4 added, 6 trimmed, 7 exited |
|---|
Top 25 holders
| Manager | Shares | Value | % of manager's 13F |
|---|
| EQT Fund Management S.a r.l. | 5,141,992 | $66.7m | 7.7% |
| Nantahala Capital Management, LLC | 3,136,376 | $40.7m | 0.7% |
| Sanofi | 2,783,096 | $36.1m | 6.8% |
| Redmile Group, LLC | 2,733,926 | $35.5m | 2.4% |
| Cormorant Asset Management, LP | 2,465,348 | $32.0m | 1.6% |
| TCG Crossover Management, LLC | 2,053,233 | $26.7m | 0.6% |
| FEDERATED HERMES, INC. | 1,618,000 | $21.0m | 0.0% |
| Casdin Capital, LLC | 1,550,000 | $20.1m | 1.0% |
| ANDERA PARTNERS | 1,538,702 | $20.0m | 9.7% |
| FMR LLC | 1,458,677 | $18.9m | 0.0% |
| Aberdeen Group plc | 846,695 | $11.0m | 0.0% |
| PERCEPTIVE ADVISORS LLC | 600,000 | $7.8m | 0.1% |
| SAMSARA BIOCAPITAL, LLC | 600,000 | $7.8m | 0.6% |
| Siren, L.L.C. | 411,250 | $5.3m | 0.1% |
| ORBIMED ADVISORS LLC | 192,740 | $2.5m | 0.0% |
| Pfizer Inc | 75,000 | $1.0m | 0.6% |
| ALPS ADVISORS INC | 49,984 | $648,792 | 0.0% |
| Bellevue Group AG | 49,248 | $639,239 | 0.0% |
| SEVEN GRAND MANAGERS, LLC | 47,600 | $617,848 | 0.0% |
| SECTORAL ASSET MANAGEMENT INC | 43,500 | $564,630 | 0.4% |
| Burkehill Global Management, LP | 35,000 | $454,300 | 0.0% |
| Quadrature Capital Ltd | 20,461 | $265,584 | 0.0% |
| TWO SIGMA INVESTMENTS, LP | 18,072 | $234,575 | 0.0% |
| HRT FINANCIAL LP | 17,075 | $221,000 | 0.0% |
| GOLDMAN SACHS GROUP INC | 11,800 | $153,164 | 0.0% |
Every holder, line by line, and the full history since 2013: yf.Client().holders("AGMB"). AGMB price history · All 13F data
Get a free API keySee history bundlesDownload free samples